This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Mesothelioma Symposium Gains Dedicated, Passionate Sponsor In The Nemeroff Law Firm

DALLAS, March 6, 2013 /PRNewswire/ -- The Nemeroff Law Firm, a leading litigation firm and advocate for mesothelioma victims and their families, has extended its support for the Mesothelioma Applied Research Foundation by sponsoring the 2013 Meso Foundation Symposium. The conference takes place in Las Vegas on March 7-8 and brings the top minds in legal, medical and mesothelioma research together with patients, caregivers and families in a collaborative and informative venue to discuss the disease, its causes and treatments.

(Photo: )

The Mesothelioma Applied Research Foundation is a national non-profit organization dedicated to ending the suffering caused by mesothelioma by funding research, providing education and support for patients and their families, and advocating for federal funding for continued research. Mesothelioma is a rare type of cancer that occurs in the protective lining of internal organs and is linked directly to exposure to asbestos, a regulated, fibrous mineral used extensively by manufacturers and builders.

"Malignant mesothelioma is a totally preventable disease, and although asbestos is regulated in this country, it is estimated that 1.3 million construction and general industry workers are currently still being exposed to asbestos," said Rick Nemeroff, founder of The Nemeroff Law Firm. "Our firm is honored to participate in the Mesothelioma Applied Research Foundation Symposium and to continue our long-standing effort to raise mesothelioma awareness and energize efforts to find a cure for this disease."

The Nemeroff Law Firm is dedicated to helping individuals and families who suffer from asbestos related mesothelioma. The firm focuses on delivering the best possible results for its clients in the quickest possible timeframe. Beyond the courtroom, the firm is an active and dedicated advocate for mesothelioma research and patients' rights, contributing to the mesothelioma community and sponsoring important events such as the Meso Foundation Symposium.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,813.39 +1.20 0.01%
S&P 500 2,088.87 -0.27 -0.01%
NASDAQ 5,116.1430 +13.3350 0.26%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs